XML 33 R22.htm IDEA: XBRL DOCUMENT v3.25.2
Stockholders’ Equity
6 Months Ended
Jun. 30, 2025
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Shareholders’ Equity
Common Stock Repurchases
On May 6, 2020, Kemper’s Board of Directors authorized the repurchase of up to an additional $200.0 million of Kemper’s common stock, in addition to $133.3 million remaining under the August 6, 2014 authorization, bringing the remaining share repurchase authorization to approximately $333.3 million. As of June 30, 2025, the remaining share repurchase authorization was $100.3 million under the repurchase program. On August 4, 2025, Kemper’s Board of Directors approved a new share repurchase authorization, under which the Company is authorized to repurchase $500.0 million of Kemper’s common stock. For further information, please refer to Note 20 - Subsequent Events.
During the three months ended June 30, 2025, Kemper repurchased and retired approximately 446,000 shares of its common stock under its share repurchase authorization for an aggregate cost of $28.5 million and an average cost per share of $64.04. Kemper did not repurchase any shares during the three months ended June 30, 2024.
During the six months ended June 30, 2025, Kemper repurchased and retired approximately 509,000 shares of its common stock under its share repurchase authorization for an aggregate cost of $32.5 million and an average cost per share of $63.90. Kemper did not repurchase any shares during the six months ended June 30, 2024.
Employee Stock Purchase Plan
During the three months ended June 30, 2025 and 2024, the Company issued 16,000 and 18,000 shares under the Kemper Employee Stock Purchase Plan (“ESPP”) at a discounted price of $54.86 and $50.43 per share, respectively. Compensation costs charged against income were $0.2 million during the three months ended June 30, 2025 and 2024, respectively.
During the six months ended June 30, 2025 and 2024, the Company issued 28,000 and 33,000 shares under the Kemper ESPP, respectively, at an average discounted price of $55.73 and $51.41 per share. Compensation costs charged against income were $0.3 million for the six months ended June 30, 2025 and 2024.